Gene therapy shows long-term success in hemophilia B patients
A gene transfer approach to treat Bleeding Disorder Hemophilia B is safe and effective long -term, as scientists at St. Jude Children’s Research Hospital and University College London report today thirteen years of follow -up data. Hemophilia B is a rare genetic disorder caused by insufficient levels of a circulating protein called factor ix, which […]
